Radiosensitivity and the cell cycle

Cancer Journal from Scientific American

Volumn 5, Issue 4, 1999, Pages 194-204

  Bernhard, Eric J ^a   McKenna, W Gillies ^a   Muschel, Ruth J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE; CELL CYCLE G2 PHASE; DNA STRAND BREAKAGE; GENE ACTIVATION; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; RADIATION TOLERANCE;

EID: 0032703261     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. Howard A, Pelc SR. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity 1953;6[suppl]:261-273.
2. Amundson SA, Myers TG, Fornace AJ Jr. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 1998;17:3287-3299.
3. Evan G, Litdewood T. A matter of life and cell death. Science 1998;281:1317-1322.
4. Lee J, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 1993;90:5742-5746.
5. Kastan MB, Onyekwere O, Sidransky D et al. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
6. Fan S, el-Deiry WS, Bae I et al. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 1994;54:5824-5830.
7. Pardo FS, Su M, Borek C et al. Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat Res 1994;140:180-185.
8. Bristow RG, Jang A, Peacock J et al. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene 1994;9:1527-1536.
9. Bristow RG, Hu Q, Jang A et al. Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation. Oncogene 1998;16:1789-1802.
10. Haas-Kogan DA, Yount G, Haas M et al. p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys 1996;36:95-103.
11. Yount GL, Haas-Kogan DA, Vidair CA et al. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res 1996;56:500-506.
12. 1 checkpoint control is an early step in carcinogenesis, independent of p53 status. Cancer Res 1999;59:1008-1014.
13. Slichenmyer WJ, Nelson WG, Slebos RJ et al. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 1993;53:4164-4168.
14. Coco Martin JM, Balkenende A, Verschoor T et al. Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. Cancer Res 1999;59:1134-1140.
15. Fan S, Chang JK, Smith ML et al. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene 1997;14:2127-2136.
16. Wouters BG, Giaccia AJ, Denko NC et al. Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res 1997;57:4703-4706.
17. 2 arrest after DNA damage. Science 1998;282:1497-1501.
18. Elkind MM, Han A, Volz K. Radiation response of mammalian cells grown in culture: IV. Dose dependence of division delay and post-irradiation growth of surviving and nonsurviving Chinese hamster cells. J Natl Cancer Inst 1963;30:705-721.
19. Hittelman WN, Rao PN. Premature chromosome condensation: I. Visualization of x-ray-induced chromosome damage in interphase cells. Mutat Res 1974;23:251-258.
20. Weinert TA, Hartwell LH. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 1988;241:317-322.
21. Weinert TA. Dual cell cycle checkpoints sensitive to chromosome replication and DNA damage in the budding yeast Saccharomyces cerevisiae. Radiat Res 1992;132:141-143.
22. Weinert TA, Kiser GL, Hartwell LH. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev 1994;8;652-665.
23. 2 arrest. Radiat Res 1978;76:292-307.
24. Kimler B, Leeper D, Snyder M et al. Modification of radiation-induced division delay by caffeine analogues and dibutyryl cyclic AMP. Int J Radiat Biol 1982;41:47-58.
25. Musk S, Steel G. Override of the radiation-induced mitotic block in human tumour cells by methylxanthines and its relationship to the potentiation of cytotoxicity. Int J Radiat Biol 1990;57:1105-1112.
26. 2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine. Radiat Res 1994;140:393-400.
27. 2 delay causes HeLa cells to undergo apoptosis instead of mitotic death. Int J Radiat Biol 1996;69:575-584.
28. Begemann M, Kashimawo SA, Heitjan DF et al. Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity. Anticancer Res 1998;18:2275-2282.
29. 2 checkpoint function in cancer cells with disrupted p53. J Natl Cancer Inst 1996;88:956-965.
30. 2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Res 1998;58:5701-5706.
31. McKenna WG, Weiss MC, Endlich B et al. Synergistic effect of the v-myc oncogene with Hras on radioresistance. Cancer Res 1990;50:97-102.
32. 2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes v-myc and H-ras. Radiat Res 1991;125:283-287.
33. 2 arrest and cell survival following ionizing radiation. Cancer Res 1994;54:5194-5197.
34. Su LN, Little JB. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen. Radiat Res 1993;133:73-79.
35. Su LN, Little JB. Transformation and radiosensitivity of human diploid skin fibroblasts transfected with activated ras oncogene and SV40 T-antigen. Int J Radiat Biol 1992;62:201-210.
36. 2 block induced by ionizing radiation. Cancer Res 1991;51:5113-5117.
37. Sigrist S, Jacobs H, Stratmann R et al. Exit from mitosis is regulated by Drosophila fizzy and the sequential destruction of cyclins A, B and B3. EMBO J 1995;14:4827-4838.
38. Sherwood SW, Kung AL, Roitelman J et al. In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal. Proc Natl Acad Sci USA 1993;90: 3353-3357.
39. cdc2. Cell 1989;58: 833-846.
40. 1 in mammalian fibroblasts. Science 1993;259:1908-1912.
41. Norbury CA, Nurse P. Animal cell cycles and their control. Annu Rev Biochem 1992;61:441-470.
42. 1 cyclins. Cell 1993;73:1059-1065.
43. Maity A, McKenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 1994;31:1-13.
44. King RW, Jackson PK, Kirschner MW. Mitosis in transition. Cell 1994;79;563-570.
45. Hatakeyama M, Herrera R, Makela T et al. The cancer cell and the cell cycle clock. CSH Symp Quant Biol 1994;59:1-10.
46. Solomon MJ, Lee T, Kirschner MW. Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol Biol Cell 1992;3:13-27.
47. Krek W, Nigg EA. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J 1991;10:3331-3341.
48. Norbury C, Blow J, Nurse P. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J 1991;10;3321-3329.
49. Mueller PR, Coleman TR, Kumagai A et al. Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 1995;270:86-90.
50. Furnari B, Rhind N, Russell P. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 1997;277:1495-1497.
51. 2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 1997;16:545-554.
52. Palmer A, Gavin AC, Nebreda AR. A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1. EMBO J 1998;17:5037-5047.
53. Hoffmann I, Clarke PR, Marcote MJ et al. Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J 1993;12:53-63.
54. Sanchez Y, Wong C, Thoma RS et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997;277:1497-1501.
55. Peng CY, Graves PR, Ogg S et al. C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ 1998;9:197-208.
56. Matsuoka S, Huang M, Elledge SJ. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998;282:1893-1897.
57. cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Res 1990;50:3767-3771.
58. cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Res 1992;52:1817-1822.
59. Muschel RJ, Zhang HB, Iliakis G et al. Effects of ionizing radiation on cyclin expression in Hela cells. Radiat Res 1992;132:153-157.
60. Muschel RJ, Zhang HB, McKenna WG. Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in Hela cells. Cancer Res 1993;53:1128-1135.
61. Woloschak GE, Chang-Liu CM, Jones PS et al. Modulation of gene expression in Syrian hamster embryo cells following ionizing radiation. Cancer Res 1990;50:339-344.
62. 2 delay in HeLa cells. Cancer Res 1997;57:753-758.
63. Markiewicz D, Flick M, Maity A et al. The effects of radiation on the expression of a newly cloned and characterized rat cyclin B mRNA. Int J Radiat Oncol Biol Phys 1994;28:135-144.
64. 2 arrest following DNA damage. Oncogene 1996;13:1647-1657.
65. Datta R, Hass R, Gunji H et al. Down-regulation of cell cycle control genes by ionizing radiation. Cell Growth Differ 1992;3:637-644.
66. 2 blocks, cyclin B expression and cdc2 expression in human squamous carcinoma cell lines with different radiosensitivities. Radiother Oncol 1994;33:217-227.
67. 2 arrest in human cells. J Cell Biol 1996;134:963-970.
68. Jackman M, Firth M, Pines J. Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J 1995;14;1646-1654.
69. 2 checkpoint. EMBO J 1998;17:2728-2735.
70. Yang J, Bardes ES, Moore JD et al. Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev 1998;12:2131-2143.
71. Hagting A, Karlsson C, Clute P et al. MPF localization is controlled by nuclear export. EMBO J 1998;17:4127-4138.
72. Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 1998;141:875-885.
73. 2 arrest induced by nitrogen mustard. Proc Natl Acad Sci USA 1994;91:9480-9484.
74. O'Connor PM, Jackman J, Jondle D et al. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 1993;53:4776-4780.
75. O'Connor PM, Ferris DK, White GA et al. Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ 1992;3:43-52.
76. Barth H, Hoffmann I, Kinzel V. Radiation with 1 Gy prevents the activation of the mitotic inducers mitosis-promoting factor (MPF) and cdc25-C in HeLa cells. Cancer Res 1996;56:2268-2272.
77. 2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase. J Biol Chem 1998:273;33455-33464.
78. Cox LS, Lane DP. Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 1995;17:501-508.
79. 2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 1995;10:2263-2270.
80. 2/M by p53. Oncogene 1995;10:109-115.
81. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995;92:8493-8497.
82. 2/M progression. Mol Cell 1997;1:3-11.
83. Medema RH, Klompmaker R, Smits VA et al. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene 1998;16:431-441.
84. 2 arrest in human cells. Oncogene 1998;17:673-684.
85. Filmus J, Robles AI, Shi W et al. Induction of cyclin D1 overexpression by activated ras. Oncogene 1994;9:3627-3633.
86. Albanese C, Johnson J, Watanabe G et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 1995;270:23589-23597.
87. Winston JT, Coats SR, Wang YZ et al. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 1996;12:127-134.
88. Aktas H, Cai H, Cooper GM. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol 1997;17:3850-3857.
89. Bosch F, Jares P, Campo E et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994;84:2726-2732.
90. Motokura T, Bloom T, Kim HG et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991;350:512-515.
91. Fan J, Bertino JR. K-ras modulates the cell cycle via both positive and negative regulatoty pathways. Oncogene 1997;14:2595-2607.
92. Galaktionov K, Jessus C, Beach D. Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev 1995;9:1046-1058.
93. FitzGerald TJ, Daugherty C, Kase K et al. Activated human N-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less effectively at low dose rate. Am J Clin Oncol 1985;8:517-522.
94. Piroll, K, Tong Y, Villegas Z et al. Oncogene-transformed NIH 3T3 cells display radiation resistance levels indicative of a signal transduction pathway leading to the radiation-resistant phenotype. Radiat Res 1993;135:234-243.
95. Samid D, Miller AC, Rimoldi D et al. Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression. Radiat Res 1991;126:244-250.
96. Sklar MD. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 1988;239:645-647.
97. Ling CC, Endlich B. Radioresistance induced by oncogenic transformation. Radiat Res 1989;120:267-279.
98. Ong A, Li WX, Ling CC. Low-dose-rate irradiation of rat embryo cells containing the Ha-ras oncogene. Radiat Res 1993;134:251-255.
99. Hermens A, Bentvelzen P. Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line. Cancer Res 1992;52:3073-3082.
100. ras isoprenylation. Int J Cancer 1993;53:302-307.
101. Bruyneel EA, Storme GA, Schallier DC et al. Evidence for abrogation of oncogene-induced radioresistance of mammary cancer cells by hexadecylphosphocholine in vitro. Eur J Cancer 1993;29A:1958-1963.
102. Harris JF, Chambers AF, Tam ASK. Some ras-transformed cells have increased radiosensitivity and decreased repair of sublethal radiation damage. Somat Cell Molec Genet 1990;16:39-48.
103. Alapetite C, Baroche C, Remvikos Y et al. Studies on the influence of the presence of an activated ras oncogene on the in vitro radiosensitivity of human mammary epithelial cells. Int J Radiat Biol 1991;59:385-396.
104. Mendonca MS, Boukamp P, Stanbridge EJ et al. The radiosensitivity of human keratinocytes: influence of activated c-H-ras oncogene expression and tumorigenicity. Int J Radiat Biol 1991;59:1195-1206.
105. Suzuki K, Watanabe M, Miyoshi J. Differences in effects of oncogenes on resistance of gamma rays, ultraviolet light, and heat shock. Radiat Res 1992;129:157-162.
106. FitzGerald TJ, Santucci MA, Das I et al. The v-abl, c-fms, or v-myc oncogene induces gamma radiation resistance of hematopoietic progenitor cell line 32d cl 3 at clinical low dose rate. Int J Radiat Oncol Biol Phys 1991;21:1203-1210.
107. 2 delay. Oncogene 1996;12:237-245.
108. Metzger L, Iliakis G. Kinetics of DNA double-strand break repair throughout the cell cycle as assayed by pulsed field gel electrophoresis in CHO cells. Int J Radiat Biol 1991;59:1325-1339.
109. McKenna WG, Weiss MA, Bakanauskas VJ et al. The role of the Hras oncogene in radiation resistance and metastasis. Int J Radiat Oncol Biol Phys 1990;18:849-860.
110. Iliakis G, Metzher L, Muschel RJ et al. Induction and repair of DNA double strand breaks in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and V-myc. Radiat Res 1990;50:6575-6579.
111. Kato K, Cox AD, Hisaka MM et al. Isoprenoid addition to ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci USA 1992;89:6403-6407.
112. Sebti S, Hamilton A. Inhibition of ras prenylation: a novel approach to cancer chemotherapy. Pharmacol Ther 1997;74:103-114.
113. James G, Brown M, Cobb M et al. Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-ras-transformed rat-1 cells, but not in untransformed cells. J Biol Chem 1994;269:27705-27714.
114. Kohl NE, Mosser SD, deSolms SJ et al. Selective inhibition of ras dependent transformation by a farnesyltransferase inhibitor. Science 1993;260:1934-1936.
115. Sepp-Lorenzino L, Ma Z, Rands E et al. A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res 1995;55:5302-5309.
116. Lerner E, Qian Y, Blaskovich M et al. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic ras signalling by inducing cytoplasmic accumulation of inactive ras-raf complexes. J Biol Chem 1995;270:26802-26806.
117. Bernhard EJ, Kao G, Cox AD et al. The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts. Cancer Res 1996;56;1727-1730.
118. Bernhard EJ, McKenna WG, Hamilton AD et al. Inhibiting ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes. Cancer Res 1998;58;1754-1761.
119. Kikuchi A, Demo SD, Ye ZH et al. ralGDS family members interact with the effector loop of ras p21. Mol Cell Biol 1994;14:7483-7491.
120. Kishida S, Koyama S, Matsubara K et al. Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator. Oncogene 1997;15:2899-2907.
121. Hofer F, Fields S, Schneider C et al. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA 1994;91:11089-11093.
122. Diaz-Meco MT, Lozano J, Municio MM et al. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J Biol Chem 1994;269:31706-31710.
123. Wolthuis RM, Bauer B, van't Veer LJ et al. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene 1996;13:353-362.
124. Vavvas D, Li X, Avruch J et al. Identification of Norel as a potential Ras effector. J Biol Chem 1998;273:5439-5442.
125. Downward J. Ras signalling and apoptosis. Curr Opin Genet Dev 1998;8;49-54.
126. Marais R, Light Y, Paterson HF et al. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. Embo J 1995;14:3136-3145.
127. Kasid U, Suy S, Dent P et al. Activation of Raf by ionizing radiation. Nature 1996;382;813-816.
128. Kasid U, Pfeifer A, Weichselbaum R et al. The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science 1987;237:1039-1041.
129. Kasid U, Pfeifer A, Brennan BM et al. Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science 1989;243:1354-1356.
130. Gupta AJ. Unpublished data.
131. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997;385:544-548.
132. White M, Nicholette C, Minden A et al. Multiple ras functions can contribute to mammalian cell transformation. Cell 1995;80:533-541.
133. Chen RH, Su YH, Chuang RL et al. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene 1998;17:1959-1968.
134. Cardone MH, Roy N, Stennicke HR et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318-1321.
135. Qiu RG, Chen J, McCormick F et al. A role for Rho in Ras transformation. Proc Natl Acad Sci USA 1995;92:11781-11785.
136. Qiu RG, Chen J, Kirn D et al. An essential role for Rac in Ras transformation. Nature 1995;374:457-459.
137. Joneson T, White MA, Wigler MH et al. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 1996:271;810-812.
138. Renshaw MW, Lea-Chou E, Wang JY. Rac is required for v-Abl tyrosine kinase to activate mitogenesis. Curr Biol 1996;6:76-83.
139. Olson MF, Paterson HF, Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 1998;394:295-299.
140. Minden A, Lin A, McMahon M et al. Differential activation of ERK and JNK mitogen-activated protein kinases by raf-1 and MEKK Science 1994;266:1719-1723.
141. Lim L, Manser E, Leung T et al. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. Eur J Biochem 1996;242:171-185.
142. Kharbanda S, Saleem A, Datta R et al. Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2. Cancer Research 1994;54:1412-1414.
143. Nishii K, Kabarowski JH, Gibbons DL et al. ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block Oncogene 1996;13:2225-2234.
144. Powell S, Defrank J, Connell P et al. Differential sensitivity of p53- and p53+ cells to caffeine-induced radiosensitization and override of G(2) delay. Cancer Res 1995;55:1643-1648.
145. 1 checkpoint-competent cells. Cancer Res 1995;55:1639-1642.